These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11494577)

  • 1. [Recurrence of febrile convulsions after the first diphtheria-pertussis-tetanus vaccination and measles vaccination in children with febrile convulsions: a questionnaire survey in Takamatsu City].
    Miyake S; Fujita M; Endo C; Taoka N; Kuzuhara M
    No To Hattatsu; 2001 Jul; 33(4):336-41. PubMed ID: 11494577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infant with febrile convulsions/incidental convulsions in the history: how does one proceed with diphtheria-pertussis-tetanus (DPT) and mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Burtzlaff C
    Kinderarztl Prax; 1993 Nov; 61(9):339-40. PubMed ID: 8114462
    [No Abstract]   [Full Text] [Related]  

  • 3. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.
    Farrington P; Pugh S; Colville A; Flower A; Nash J; Morgan-Capner P; Rush M; Miller E
    Lancet; 1995 Mar; 345(8949):567-9. PubMed ID: 7619183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B.
    Sun Y; Christensen J; Hviid A; Li J; Vedsted P; Olsen J; Vestergaard M
    JAMA; 2012 Feb; 307(8):823-31. PubMed ID: 22357833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Australian Childhood Immunisation Register for vaccine safety data linkage.
    Gold M; Dugdale S; Woodman RJ; McCaul KA
    Vaccine; 2010 Jun; 28(26):4308-11. PubMed ID: 20430123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history of convulsions and use of pertussis vaccine.
    Livengood JR; Mullen JR; White JW; Brink EW; Orenstein WA
    J Pediatr; 1989 Oct; 115(4):527-31. PubMed ID: 2552066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adverse events following immunization: AEFI in 17 children between 0 and 2 years of age].
    Taraszkiewicz F; Bogus-Parafieniuk W; Ołdak E; Sulik A
    Przegl Epidemiol; 1994; 48(4):505-9. PubMed ID: 7597191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.
    Barlow WE; Davis RL; Glasser JW; Rhodes PH; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Ward JI; Marcy SM; DeStefano F; Chen RT; Immanuel V; Pearson JA; Vadheim CM; Rebolledo V; Christakis D; Benson PJ; Lewis N;
    N Engl J Med; 2001 Aug; 345(9):656-61. PubMed ID: 11547719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine.
    Scheifele DW; Bjornson G; Halperin SH; Mitchell L; Boraston S
    CMAJ; 1994 Jan; 150(1):29-35. PubMed ID: 8275406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau.
    Fisker AB; Biering-Sørensen S; Lund N; Djana Q; Rodrigues A; Martins CL; Benn CS
    Vaccine; 2016 Aug; 34(38):4551-4557. PubMed ID: 27475473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
    Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
    Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse events following diphtheria, pertussis and tetanus vaccinations and factors associated with severity].
    Freitas FR; Sato HK; Aranda CM; Arantes BA; Pacheco MA; Waldman EA
    Rev Saude Publica; 2007 Dec; 41(6):1032-41. PubMed ID: 18066473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surveillance of adverse events following immunization in Henan Province, China between 2010-2011].
    Ye Y; Wang CS; Ma YT; Lu MX; Zhang XX; Zhang YY; Guo WS
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):466-71. PubMed ID: 23791064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of serious neurologic disease after immunization of young children in Britain and Ireland.
    Ward KN; Bryant NJ; Andrews NJ; Bowley JS; Ohrling A; Verity CM; Ross EM; Miller E
    Pediatrics; 2007 Aug; 120(2):314-21. PubMed ID: 17671057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoiding missed opportunities for immunization in the Central African Republic: potential impact on vaccination coverage.
    Kahn JG; Mokdad AH; Deming MS; Roungou JB; Boby AM; Excler JL; Waldman RJ
    Bull World Health Organ; 1995; 73(1):47-55. PubMed ID: 7704925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.
    Rosen JB; Breman JG; Manclark CR; Meade BD; Collins WE; Lobel HO; Saliou P; Roberts JM; Campaoré P; Miller MA
    Malar J; 2005 Nov; 4():53. PubMed ID: 16271153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-appropriate vaccination against measles and DPT-3 in India - closing the gaps.
    Awofeso N; Rammohan A; Iqbal K
    BMC Public Health; 2013 Apr; 13():358. PubMed ID: 23594400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic antipyretics for prevention of febrile seizures following vaccination.
    Monfries N; Goldman RD
    Can Fam Physician; 2017 Feb; 63(2):128-130. PubMed ID: 28209678
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination of children in Japan.
    Nishi M; Miyake H; Ito Y; Kagiichi S; Kimura M; Suzuki A; Takaoka A; Tago N; Nagase K
    Asia Pac J Public Health; 1990; 4(2-3):128-31. PubMed ID: 2278761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.